Rob Hooper, national sales manager for OTC with Actavis Pharmaceutical, sat down with DSN to discuss how Actavis is preparing for the inaugural NACDS Total Store Expo. Actavis Pharmaceutical, one of the leaders in the OTC private label industry and recently acquired by Watson Pharmaceutical, plans to leverage its extensive experience within the prescription medicine business to offer best-in-class options across store brand products.
Health benefit plan cost trend rates for 2016 will increase for most medical plan options and increase substantially for prescription drug coverage to double-digit rates, according to forecasts compiled in the 2016 Segal Health Plan Cost Trend Survey, Segal’s nineteenth annual survey of health plan cost trends. Trend is the forecast of annual gross per capita claims cost increases.
The Wall Street Journal is examining the potential that biosimilars can have in the market for biotechnology drugs by looking at how they have been received in Europe to highlight their potential in the U.S. following the launch of Zarxio, the first U.S. biosimilar, earlier this month.
The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.
TruTag Technologies is looking to impact the food and drug industry with its edible security platform. “TruTags,” the company's microtags, can help to authenticate products without packaging or labels. DSN recently spoke with Kent Mansfield, president of TruTag Technologies.
In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.
The DEA announced on Tuesday that the 10th National Prescription Drug Take-Back will take place across the United States on Sept. 26 — except for in Pennsylvania and Delaware where the event will take place on Sept. 12.
The average lost time worker's compensation claim for workers using opioid painkillers can total as much as $117,000 — 900% higher than the cost for workers who do not take opioid painkillers, the National Safety Council says.